Molecular medicine: Promises and patience

Netherlands Journal of Medicine

Volumn 71, Issue 3, 2013, Pages 107-108

  Levi, M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; DYSTROPHIN; OLIGONUCLEOTIDE;

CELL PROLIFERATION; DNA IMMUNIZATION; DUCHENNE MUSCULAR DYSTROPHY; DYSTROPHIN GENE; EDITORIAL; GENE; GENE MUTATION; GENE THERAPY; GENETIC VARIABILITY; HEMOCHROMATOSIS; HEMOPHILIA B; HUMAN; IMMUNE RESPONSE; MELANOMA; MOLECULAR GENETICS; MOLECULAR MEDICINE; MYELOPROLIFERATIVE DISORDER; RNA SPLICING; SICKLE CELL ANEMIA;

HUMANS; MOLECULAR MEDICINE;

EID: 84878308209     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (19)

1. Goemans NM, Tulinius M, van den Akker JT, et al. Systemic Administration of PRO051 in Duchenne's Muscular Dystrophy. N Engl J Med. 2011;364:1513-22.
2. Stroes ES, Nierman MC, Meulenberg JJ, et al. Intramuscular administration o f A AV1-lipoprotein l ipase S 447X l owers t riglycerides in lipoprotein lipase-deficient patients. Arterioscler Thromb Vasc Biol. 2008;28:2303-4.
3. Nathwani AC, Tuddenham EGD, Rangarajan S, et al. Adenovirus-Associated Virus Vector ÇôMediated Gene Transfer in Hemophilia B. N Engl J Med. 2011;365:2357-65.
4. Thielen N, Ossenkoppele GJ, Schuurhuis GJ, Janssen JJ. New insights into the pathogenesis of chronic myeloid leukaemia: towards a path to cure. Neth J Med. 2011;69:430-40.
5. Kater AP, Wittebol S, Chamuleau ME, van Gelder M, Oers MH; Hovon CLL Working party. Dutch guidelines for diagnosis and treatment of chronic lymphocytic leukaemia 2011. Neth J Med. 2011;69:422-9.
6. te Raa GD, van Oers MH, Kater AP. Monoclonal B-cell lymphocytosis: recommendations from the Dutch Working Group on CLL for daily practice. Neth J Med. 2012;70:236-41.
7. de Jonge HJ, Huls G, de Bont ES. Gene expression profiling in acute myeloid leukaemia. Neth J Med. 2011;69:167-76.
8. Schouten M, van 't Veer C, van der Poll T, Levi M. Effect of the factor V Leiden mutation on the incidence and outcome of severe infection and sepsis. Neth J Med. 2012;70:306-10.
9. Leebeek FW, Smalberg JH, Janssen HL. Prothrombotic disorders in abdominal vein thrombosis. Neth J Med. 2012;70:400-5.
10. van Esch AA, de Vries E, te Morsche RH, van Oijen MG, Jansen JB, Drenth JP. Catechol-O-methyltransferase (COMT) gene variants and pain in chronic pancreatitis. Neth J Med. 2011;69:330-4.
11. Levi M. Clinical molecular medicine has finally arrived. Neth J Med. 2011;69:408-9.
12. Barkhan P. Genetics of haemoglobin. Guys Hosp Rep. 1967;116:307-22.
13. Rees DC, Olujohungbe AD, Parker NE, Stephens AD, Telfer P, Wright J. Guidelines for the management of the acute painful crisis in sickle cell disease. Br J Haematol. 2003;120:744-52.
14. Wheeler CJ, Kowdley KV. Hereditary hemochromatosis: a review of the genetics, mechanism, diagnosis, and treatment of iron overload. Compr Ther. 2006;32:10-6.
15. Bins AD, van den Berg JH, Oosterhuis K, Haanen JBAG. Recent advances towards clinical application of DNA vaccines. Neth J Med. 2013;71:109-15.
16. Stroes E, Besseling J, Hovingh GK. Antisense oligonucleotides in the treatment of lipid disorders: Pitfalls and promises. Neth J Med. 2013;71:118-22.
17. Graaff LCG, van Schaik RHN, van Gelder T. A clinical approach to pharmacogenetics. Neth J Med. 2013;71:145-53.
18. Zhang H, Lowenberg EC, Crosby JR, et al. Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: a novel antithrombotic strategy with lowered bleeding risk. Blood. 2010;116:4684-92.
19. Blagden SP, Willis AE. The biological and therapeutic relevance of mRNA translation in cancer. Nat Rev Clin Oncol. 2011;8:280-91.